Fiera Capital (Canada)
ANIP icon

Fiera Capital (Canada)’s ANI Pharmaceuticals ANIP Stock Holding History

Fiera Capital (Canada)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-152,696
Closed -$7.56M – 648
2017
Q1 		$7.56M Sell
152,696
-5,748
-4% -$323K 0.04% 255
2016
Q4 		$9.61M Sell
158,444
-26,033
-14% -$1.59M 0.05% 240
2016
Q3 		$12.2M Sell
184,477
-5,456
-3% -$341K 0.07% 223
2016
Q2 		$10.6M Buy
+189,933
New +$9.23M 0.06% 236

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fiera Capital (Canada)'s ANIP Position: Q2 2017 in Review

Fiera Capital (Canada) sold out of ANI Pharmaceuticals (ANIP) in Q2 2017, closing a stake of 152,696 shares — an estimated $7.56M sold.

Fiera Capital (Canada) first reported a position in ANIP in Q2 2016 and held it in 4 quarters. The position peaked at $12.2M in Q3 2016. 151 funds tracked by Wall St. Rank hold ANIP as of Q2 2017.

  • Fiera Capital (Canada) reported no remaining ANI Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 152,696 ANI Pharmaceuticals shares in Q2 2017, an estimated $7.56M.
  • Fiera Capital (Canada) first reported a position in ANI Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • Fiera Capital (Canada)'s ANI Pharmaceuticals position peaked at $12.2M in Q3 2016.
  • 151 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2017, filed 10 Aug 2017.